BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 36083239)

  • 1. Hsa-microRNA-370-3p targeting Snail and Twist1 suppresses IL-8/STAT3-driven hepatocellular carcinoma metastasis.
    Peng S; Chen Y; Li T; Mao J; Yang P; Zou B; Luo L; Zhang W; Wang W; Xie R; Li J; Zeng L
    Cancer Sci; 2022 Dec; 113(12):4120-4134. PubMed ID: 36083239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Twist1-related miR-26b-5p suppresses epithelial-mesenchymal transition, migration and invasion by targeting SMAD1 in hepatocellular carcinoma.
    Wang Y; Sun B; Zhao X; Zhao N; Sun R; Zhu D; Zhang Y; Li Y; Gu Q; Dong X; Wang M; An J
    Oncotarget; 2016 Apr; 7(17):24383-401. PubMed ID: 27027434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-203 inhibits augmented proliferation and metastasis of hepatocellular carcinoma residual in the promoted regenerating liver.
    Zheng XB; Chen XB; Xu LL; Zhang M; Feng L; Yi PS; Tang JW; Xu MQ
    Cancer Sci; 2017 Mar; 108(3):338-346. PubMed ID: 28100026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-345 inhibits tumor metastasis and EMT by targeting IRF1-mediated mTOR/STAT3/AKT pathway in hepatocellular carcinoma.
    Yu M; Xue H; Wang Y; Shen Q; Jiang Q; Zhang X; Li K; Jia M; Jia J; Xu J; Tian Y
    Int J Oncol; 2017 Mar; 50(3):975-983. PubMed ID: 28098858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CASC15 promotes epithelial to mesenchymal transition and facilitates malignancy of hepatocellular carcinoma cells by increasing TWIST1 gene expression via miR-33a-5p sponging.
    Li Y; Chen G; Yan Y; Fan Q
    Eur J Pharmacol; 2019 Oct; 860():172589. PubMed ID: 31401158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA miR-509-3p inhibit metastasis and epithelial-mesenchymal transition in hepatocellular carcinoma.
    Zhang H; Liu S; Chen L; Sheng Y; Luo W; Zhao G
    Bioengineered; 2021 Dec; 12(1):2263-2273. PubMed ID: 34115554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hsa-circ_0058106 induces EMT and metastasis in laryngeal cancer via sponging miR-153 and inducing Twist1 nuclear translocation.
    Zhang X; Wu N; Wang J
    Cell Oncol (Dordr); 2021 Dec; 44(6):1373-1386. PubMed ID: 34738200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Silencing of hsa_circ_0101145 reverses the epithelial-mesenchymal transition in hepatocellular carcinoma via regulation of the miR-548c-3p/LAMC2 axis.
    Jin J; Liu H; Jin M; Li W; Xu H; Wei F
    Aging (Albany NY); 2020 Jun; 12(12):11623-11635. PubMed ID: 32554866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-1306-3p targets FBXL5 to promote metastasis of hepatocellular carcinoma through suppressing snail degradation.
    He ZJ; Li W; Chen H; Wen J; Gao YF; Liu YJ
    Biochem Biophys Res Commun; 2018 Oct; 504(4):820-826. PubMed ID: 30219228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-30b Suppresses Epithelial-Mesenchymal Transition and Metastasis of Hepatoma Cells.
    Sun X; Zhao S; Li H; Chang H; Huang Z; Ding Z; Dong L; Chen J; Zang Y; Zhang J
    J Cell Physiol; 2017 Mar; 232(3):625-634. PubMed ID: 27333771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-27a-3p suppresses tumor metastasis and VM by down-regulating VE-cadherin expression and inhibiting EMT: an essential role for Twist-1 in HCC.
    Zhao N; Sun H; Sun B; Zhu D; Zhao X; Wang Y; Gu Q; Dong X; Liu F; Zhang Y; Li X
    Sci Rep; 2016 Mar; 6():23091. PubMed ID: 26980408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-15a-3p suppresses the growth and metastasis of ovarian cancer cell by targeting Twist1.
    Fan B; Chen LP; Yuan YH; Xiao HN; Lv XS; Xia ZY
    Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):1934-1946. PubMed ID: 30915736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-128-3p suppresses tumor proliferation and metastasis via targeting CDC6 in hepatocellular carcinoma cells.
    Shi Y; Yan F; Wang F; Pan L
    Tissue Cell; 2021 Oct; 72():101534. PubMed ID: 33991762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-canonical signaling pathway of SNAI2 induces EMT in ovarian cancer cells by suppressing miR-222-3p transcription and upregulating PDCD10.
    Fan L; Lei H; Zhang S; Peng Y; Fu C; Shu G; Yin G
    Theranostics; 2020; 10(13):5895-5913. PubMed ID: 32483426
    [No Abstract]   [Full Text] [Related]  

  • 15. LncRNA ANCR promotes hepatocellular carcinoma metastasis through upregulating HNRNPA1 expression.
    Wen Z; Lian L; Ding H; Hu Y; Xiao Z; Xiong K; Yang Q
    RNA Biol; 2020 Mar; 17(3):381-394. PubMed ID: 31868085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hsa_circ_0003998 promotes epithelial to mesenchymal transition of hepatocellular carcinoma by sponging miR-143-3p and PCBP1.
    Song LN; Qiao GL; Yu J; Yang CM; Chen Y; Deng ZF; Song LH; Ma LJ; Yan HL
    J Exp Clin Cancer Res; 2020 Jun; 39(1):114. PubMed ID: 32552766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. lncRNA AC005224.4/miR-140-3p/SNAI2 regulating axis facilitates the invasion and metastasis of ovarian cancer through epithelial-mesenchymal transition.
    Xiong T; Wang Y; Zhang Y; Yuan J; Zhu C; Jiang W
    Chin Med J (Engl); 2023 May; 136(9):1098-1110. PubMed ID: 36939239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-500a-3p promotes cancer stem cells properties via STAT3 pathway in human hepatocellular carcinoma.
    Jiang C; Long J; Liu B; Xu M; Wang W; Xie X; Wang X; Kuang M
    J Exp Clin Cancer Res; 2017 Jul; 36(1):99. PubMed ID: 28750679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circular RNA CNOT2 knockdown regulates twist family BHLH transcription factor via targeting microRNA 409-3p to prevent breast cancer invasion, migration and epithelial-mesenchymal transition.
    Su Q; Shen H; Gu B; Zhu N
    Bioengineered; 2021 Dec; 12(1):9058-9069. PubMed ID: 34698000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-124-3p availability is antagonized by LncRNA-MALAT1 for Slug-induced tumor metastasis in hepatocellular carcinoma.
    Cui RJ; Fan JL; Lin YC; Pan YJ; Liu C; Wan JH; Wang W; Jiang ZY; Zheng XL; Tang JB; Yu XG
    Cancer Med; 2019 Oct; 8(14):6358-6369. PubMed ID: 31466138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.